Crizanlizumab 100mg/10ml solution for infusion vials

SNOMED code
39964611000001100
Active compound
Crizanlizumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
10 ml, vial
Ingredients
Crizanlizumab — 10 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Adakveo 100mg/10ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd)

in short Adakveo 100mg/10ml concentrate for inf vials

Adakveo 100mg/10ml concentrate for solution for infusion vials

SNOMED code
39653811000001109
Supplier
Novartis Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Adakveo 100mg/10ml concentrate for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 1 vial
39653911000001104   ref. pack
Discontinued


Legal category: POM
7612797525500
7613421029968
NHS Indicative Price
£1,038
• Hospital
  • • Prescription Charges

Reference packs

Crizanlizumab 100mg/10ml solution for infusion vials 1 vial
SNOMED code
39653711000001101
Quantity and unit
1 vial
Packs